Identification of novel psychoactive drug use in Sweden based on laboratory analysis-initial experiences from the STRIDA project

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 73, Issue 5, 2013, Pages 400-406

  Helander, Anders ^a   Beck, Olof ^a   Hägerkvist, Robert ^b   Hultén, Peter ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Swedish Poisons Information Centre   (Sweden)

Author keywords

Cannabinoids; Cathinone; Designer drugs; Indoles; Internet; Mass spectrometry methods; Substance abuse detection; Tryptamines

Indexed keywords

2 METHYL 3 (1 NAPHTHOYL) 1 PROPYLINDOLE; 3 (1 NAPHTHOYL) 1 PENTYLINDOLE; 4 METHYLAMPHETAMINE; 4' METHYLMETHCATHINONE; ALCOHOL; AMPHETAMINE; BENZODIAZEPINE DERIVATIVE; BUPRENORPHINE; CANNABIS; CATHINONE; COCAINE; DEXTROMETHORPHAN; ETHYL GLUCURONIDE; ETHYLMORPHINE; METHADONE; METHCATHINONE; METHYLONE; MITRAGYNINE; OPIATE; PHENAZEPAM; PREGABALIN; PSYCHOTROPIC AGENT; TRAMADOL; TRYPTAMINE DERIVATIVE;

ARTICLE; BLOOD SAMPLING; DRUG IDENTIFICATION; DRUG USE; EMERGENCY WARD; FUNGUS; INTERNET; LABORATORY TEST; LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; SWEDEN; TANDEM MASS SPECTROMETRY;

EID: 84882365939     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.3109/00365513.2013.793817     Document Type: Article

References (35)

1. S. 'L egal highs'-novel and emerging psychoactive drugs: achemical overview for the toxicologist. Clin Toxicol (Phila) 2012; 50 : 15-24.
2. Prosser JM, Nelson LS. The toxicology of bath salts: areview of synthetic cathinones. J Med Toxicol 2012; 8 : 33-42.
3. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Annual report on the state of the drugs problem in Europe. 2012. http://www.emcdda. europa. eu/publications/annual-report/2012.
4. Vardakou I, Pistos C, Spiliopoulou C. Drugs for youth via Internet and the example of mephedrone. Toxicol Lett 2011; 201 : 191-5.
5. Hill SL, Thomas SH. Clinical toxicology of newer recreational drugs. Clin Toxicol (Phila) 2011; 49 : 705-19.
6. Kronstrand R, Roman M, Thelander G, Eriksson A. Unintentional fatal intoxications with mitragynine and O-desmethyltramadol from the herbal blend Krypton. J Anal Toxicol 2011; 35 : 242-7.
7. Spiller HA, Ryan ML, Weston RG, Jansen J. Clinical experience with and analytical confi rmation of ' bath salts ' and ' legal highs ' (synthetic cathinones) in the United States. Clin Toxicol (Phila) 2011; 49 : 499-505.
8. Baron M, Elie M, Elie L. An analysis of legal highs: do they contain what it says on the tin Drug Test Anal 2011; 3 : 576-81.
9. Davies S, Wood DM, Smith G, Button J, Ramsey J, Archer R, Holt DW, Dargan PI. Purchasing ' legal highs ' on the Internet-is there consistency in what you get QJM 2010; 103 : 489-93.
10. Zukiewicz-Sobczak W, Zwolinski J, Chmielewska-Badora J, Krasowska E, Pitek J, Sobczak P, Wojtya A, Fornal E, Kuczumow A, Bili ski P. Analysis of psychoactive and intoxicating substances in legal highs. Ann Agric Environ Med 2012; 19 : 309-14.
11. Fattore L, Fratta W. Beyond THC: the new generation of cannabinoid designer drugs. Front Behav Neurosci 2011; 5 : 60.
12. Seely KA, Lapoint J, Moran JH, Fattore L. Spice drugs are more than harmless herbal blends: areview of the pharmacology and toxicology of synthetic cannabinoids. Prog Neuropsychopharmacol Biol Psychiatry 2012; 39 : 234-43.
13. Davey Z, Schifano F, Corazza O, Deluca P. e-Psychonauts: conducting research in online drug forum communities. J MenThealth 2012; 21 : 386-94.
14. Kjellgren A, Soussan C. Heaven and hell-a phenomenological study of recreational use of 4-HO-MET in Sweden. J Psychoactive Drugs 2011; 43 : 211-9.
15. Murphy CM, Dulaney AR, Beuhler MC, Kacinko S. 'B ath Salts ' and ' Plant Food ' products: the experience of one regional US poison center. J Med Toxicol 2013; 9 : 42-8.
16. Bell C, George C, Kicman AT, Traynor A. Development of arapid LC-MS/MS method for direct urinalysis of designer drugs. Drug Test Anal 2011; 3 : 496-504.
17. Björnstad K, Beck O, Helander A. Amulti-component LC-MS/MS method for detection of ten plant-derived psychoactive substances in urine. J Chromatogr BAnalyt Technol Biomed Life Sci 2009; 877 : 1162-8.
18. Nordgren HK, Beck O. Multicomponent screening for drugs of abuse: direct analysis of urine by LC-MS-MS. Ther Drug Monit 2004; 26 : 90-7.
19. Wohlfarth A, Weinmann W, Dresen S. LC-MS/MS screening method for designer amphetamines, tryptamines, and piperazines in serum. Anal Bioanal Chem 2010; 396 : 2403-14.
20. Andersson M, Gustavsson E, Stephanson N, Beck O. Direct injection LC-MS/MS method for identifi cation and quantifi cation of amphetamine, methamphetamine, 3,4-methylenedioxyamphetamine and 3,4- methylenedioxymethamphetamine in urine drug testing. J Chromatogr BAnalyt Technol Biomed Life Sci 2008; 861 : 22-8.
21. Böttcher M, Beck O, Helander A. Evaluation of anew immunoassay for urinary ethyl glucuronide testing. Alcohol Alcohol 2008; 43 : 46-8.
22. Gustavsson E, Andersson M, Stephanson N, Beck O. Validation of direct injection electrospray LC-MS/MS for confi rmation of opiates in urine drug testing. J Mass Spectrom 2007; 42 : 881-9.
23. Stephanson N, Josefsson M, Kronstrand R, Beck O. Accurate identifi cation and quantifi cation of 11-nordelta( 9)-tetrahydrocannabinol-9-carboxylic acid in urine drug testing: evaluation of adirect high effi ciency liquid chromatographic-mass spectrometric method. J Chromatogr BAnalyt Technol Biomed Life Sci 2008; 871 : 101-8.
24. Arndt T, Claussen U, Gussregen B, Schröfel S, Stürzer B, Werle A, Wolf G. Kratom alkaloids and O-desmethyltramadol in urine of a' Krypton ' herbal mixture consumer. Forensic Sci Int 2011; 208 : 47-52.
25. de Jager AD, Warner JV, Henman M, Ferguson W, Hall A. LC-MS/MS method for the quantitation of metabolites of eight commonly-used synthetic cannabinoids in human urine-an Australian perspective. J Chromatogr BAnalyt Technol Biomed Life Sci 2012; 897 : 22-31.
26. Hutter M, Broecker S, Kneisel S, Auwarter V. Identifi cation of the major urinary metabolites in man of seven synthetic cannabinoids of the aminoalkylindole type present as adulterants in ' herbal mixtures ' using LC-MS/MS techniques. J Mass Spectrom 2012; 47 : 54-65.
27. Dargan PI, Davies S, Puchnarewicz M, Johnston A, Wood DM. First reported case in the UK of acute prolonged neuropsychiatric toxicity associated with analytically confi rmed recreational use of phenazepam. Eur J Clin Pharmacol 2013; 69 : 361-3.
28. Hoyte CO, Jacob J, Monte AA, Al-Jumaan M, Bronstein AC, Heard KJ. Acharacterization of synthetic cannabinoid exposures reported to the National Poison Data system in 2010. Ann Emerg Med 2012; 60 : 435-8.
29. Wood DM, Davies S, Greene SL, Button J, Holt DW, Ramsey J, Dargan PI. Case series of individuals with analytically confi rmed acute mephedrone toxicity. Clin Toxicol (Phila) 2010; 48 : 924-7.
30. Ayres TC, Bond JW. Achemical analysis examining the pharmacology of novel psychoactive substances freely available over the internet and their impact on public (ill)health. Legal highs or illegal highs BMJ Open 2012;2:e000977. DOI:10.1136/bmjopen-2012-000977.
31. Westwell AD, Hutchings A, Caldicott DG. The identifi cation and chemical characterization of anew arylcyclohexylamine, methoxetamine, using anovel Emergency Department toxicosurveillance tool. Drug Test Anal 2013; 5 : 203-7.
32. Thelander A, Beck O, Hä gerkvist R, Hulten P. STRIDA in the fi ght against il(legal) Internet drugs. Lä kartidningen 2011; 108 : 2312-5 [in Swedish].
33. Rosenbaum CD, Carreiro SP, Babu KM. Here today, gone tomorrow. and back again Areview of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazines. J Med Toxicol 2012; 8: 15-32.
34. Simmons J, Cookman L, Kang C, Skinner C. Three cases of ' spice ' exposure. Clin Toxicol (Phila) 2011; 49 : 431-3.
35. Fass JA, Fass AD, Garcia AS. Synthetic cathinones (bath salts): legal status and patterns of abuse. Ann Pharmacother 2012; 46 : 436-41.